[{"quiz_id": "ABMS20260101_grok-4-0709_p03", "question_id": "ABMS20260101_grok-4-0709_p03-001", "question": "A 42-year-old man with acromegaly undergoes transsphenoidal resection of a growth hormone-secreting pituitary adenoma. Postoperatively, he develops polyuria with urine output exceeding 10 L/day and serum sodium of 152 mEq/L. What is the most appropriate treatment?", "options": ["Desmopressin acetate", "Fluid restriction", "Hypertonic saline infusion", "Demeclocycline", "Vasopressin infusion"], "answer": "A", "answer_index": 0, "explanation": "Postoperative diabetes insipidus from pituitary surgery causes polyuria and hypernatremia, treated with desmopressin to replace deficient antidiuretic hormone. Fluid restriction is for SIADH, not DI. Hypertonic saline worsens hypernatremia.", "generator_model": "grok-4-0709", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Endocrine", "abms_specialty": "Endocrine", "abms_source": "target_topic", "source_label_raw": "Endocrine", "source_quiz_id": "20251216T182308874Z_grok-4-0709_seed130", "source_question_id": "20251216T182308874Z_grok-4-0709_seed130-018", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251216T182308874Z_grok-4-0709_seed130", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T182308874Z_grok-4-0709_seed130.jsonl", "pred": "A", "model_outputs": "The patient’s postoperative polyuria with hypernatremia is consistent with central diabetes insipidus due to loss of ADH secretion after pituitary surgery. The standard and most appropriate therapy is replacement with a synthetic ADH analog.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_grok-4-0709_p03", "question_id": "ABMS20260101_grok-4-0709_p03-002", "question": "A 50-year-old man with cirrhosis presents with massive hematemesis. Endoscopy reveals isolated gastric varices without esophageal involvement. CT shows splenic vein thrombosis. What is the most appropriate definitive management?", "options": ["Endoscopic band ligation", "Transjugular intrahepatic portosystemic shunt", "Balloon-occluded retrograde transvenous obliteration", "Splenectomy", "Beta-blocker therapy"], "answer": "D", "answer_index": 3, "explanation": "Isolated gastric varices due to splenic vein thrombosis (sinistral portal hypertension) are best managed with splenectomy to eliminate the inflow and prevent rebleeding. TIPS is ineffective as it does not address the isolated splenic vein pathology. Band ligation is temporary and not definitive for this etiology.", "generator_model": "grok-4-0709", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "abms_specialty": "Gastrointestinal", "abms_source": "target_topic", "source_label_raw": "Gastrointestinal", "source_quiz_id": "20251216T182308874Z_grok-4-0709_seed130", "source_question_id": "20251216T182308874Z_grok-4-0709_seed130-009", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251216T182308874Z_grok-4-0709_seed130", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T182308874Z_grok-4-0709_seed130.jsonl", "pred": "D", "model_outputs": "The answer is (D) "}, {"quiz_id": "ABMS20260101_grok-4-0709_p03", "question_id": "ABMS20260101_grok-4-0709_p03-003", "question": "A 55-year-old man with idiopathic pulmonary fibrosis presents with acute worsening dyspnea. High-resolution CT shows new ground-glass opacities superimposed on fibrosis. Bronchoalveolar lavage reveals neutrophilia without infection. What is the most appropriate therapeutic approach?", "options": ["High-dose systemic corticosteroids", "Azathioprine addition to regimen", "Pirfenidone dose escalation", "Nintedanib initiation", "Lung transplantation evaluation"], "answer": "A", "answer_index": 0, "explanation": "High-dose systemic corticosteroids are the most appropriate for acute exacerbation of idiopathic pulmonary fibrosis, aiming to suppress inflammation despite limited evidence. Azathioprine is contraindicated due to increased mortality risk. Pirfenidone and nintedanib are antifibrotics for stable disease, not acute flares, and transplantation is for end-stage but not immediate management.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pulmonary", "abms_specialty": "Pulmonary", "abms_source": "topics_mapped", "source_label_raw": "pulmonology", "source_quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "source_question_id": "20251201T041413890Z_grok-4-0709_seed123-008", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251201T041413890Z_grok-4-0709_seed123", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251201T041413890Z_grok-4-0709_seed123.jsonl", "pred": "A", "model_outputs": "The patient presents with an acute exacerbation of idiopathic pulmonary fibrosis (IPF), characterized by abrupt worsening dyspnea, new ground‑glass opacities on HRCT, and BAL neutrophilia without infection. The mainstay of therapy for an acute exacerbation is high‑dose systemic corticosteroids (e.g., intravenous methylprednisolone) to dampen the inflammatory component, even though evidence is limited and the prognosis remains poor. Other options are not appropriate: azathioprine is not recommended for IPF; pirfenidone and nintedanib are antifibrotics for stable disease, not for acute exacerbations; lung transplantation evaluation is important but is not the immediate therapeutic measure.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_grok-4-0709_p03", "question_id": "ABMS20260101_grok-4-0709_p03-004", "question": "A 45-year-old man with autosomal dominant polycystic kidney disease presents with acute flank pain and hematuria. Imaging reveals a 6 cm cyst with internal septations and hemorrhage. Renal function is preserved, but he develops fever and leukocytosis. Blood cultures are negative, but cyst aspiration yields purulent fluid positive for Escherichia coli. Despite appropriate intravenous antibiotics, his symptoms persist. What is the most appropriate next step in management?", "options": ["Switch to a different antibiotic based on sensitivity testing", "Perform percutaneous cyst drainage and sclerotherapy", "Initiate long-term suppressive antibiotic therapy", "Surgical decortication of the infected cyst", "Administer intraparenchymal antibiotic infusion"], "answer": "D", "answer_index": 3, "explanation": "Surgical decortication is indicated for persistent cyst infection in polycystic kidney disease when antibiotics and drainage fail, as it allows complete removal of infected material. Percutaneous drainage often fails due to viscous cyst contents and multiloculation, while sclerotherapy is not appropriate for infected cysts. Long-term suppression or antibiotic switches do not address the source of ongoing infection.", "generator_model": "grok-4-0709", "seed": 131, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Nephrology", "abms_specialty": "Nephrology", "abms_source": "target_topic", "source_label_raw": "Nephrology", "source_quiz_id": "20251216T182308874Z_grok-4-0709_seed131", "source_question_id": "20251216T182308874Z_grok-4-0709_seed131-001", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251216T182308874Z_grok-4-0709_seed131", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T182308874Z_grok-4-0709_seed131.jsonl", "pred": "B", "model_outputs": "The answer is (B)"}, {"quiz_id": "ABMS20260101_grok-4-0709_p03", "question_id": "ABMS20260101_grok-4-0709_p03-005", "question": "A 62-year-old woman with chronic lymphocytic leukemia develops petechiae and easy bruising. Laboratory studies show hemoglobin 9.2 g/dL, platelets 12,000/μL, and white blood cells 45,000/μL with 80% lymphocytes. Bone marrow biopsy reveals 90% infiltration by small lymphocytes. She has no active infection or bleeding. What is the most likely mechanism underlying her thrombocytopenia?", "options": ["Autoimmune destruction mediated by anti-platelet antibodies", "Bone marrow suppression from leukemic infiltration", "Hypersplenism with platelet sequestration", "Drug-induced thrombocytopenia from prior chemotherapy", "Microangiopathic hemolytic anemia with consumptive thrombocytopenia"], "answer": "B", "answer_index": 1, "explanation": "In advanced chronic lymphocytic leukemia, thrombocytopenia is primarily due to bone marrow infiltration by leukemic cells, crowding out normal hematopoiesis. Autoimmune thrombocytopenia occurs in only 1-2% of cases and typically responds to steroids, while hypersplenism is less common without massive splenomegaly. Drug effects or microangiopathy are not supported by the clinical scenario.", "generator_model": "grok-4-0709", "seed": 131, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Hematology", "abms_specialty": "Hematology", "abms_source": "target_topic", "source_label_raw": "Hematology", "source_quiz_id": "20251216T182308874Z_grok-4-0709_seed131", "source_question_id": "20251216T182308874Z_grok-4-0709_seed131-002", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251216T182308874Z_grok-4-0709_seed131", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T182308874Z_grok-4-0709_seed131.jsonl", "pred": "B", "model_outputs": "The answer is (B)"}, {"quiz_id": "ABMS20260101_grok-4-0709_p03", "question_id": "ABMS20260101_grok-4-0709_p03-006", "question": "A 28-year-old man with common variable immunodeficiency presents with recurrent sinopulmonary infections. Immunoglobulin levels show IgG 150 mg/dL, IgA <5 mg/dL, and IgM 20 mg/dL. He has absent responses to protein and polysaccharide vaccines. Genetic testing reveals a heterozygous mutation in the TACI gene. What is the most appropriate long-term management strategy?", "options": ["Monthly intravenous immunoglobulin replacement", "Prophylactic antibiotics with trimethoprim-sulfamethoxazole", "Hematopoietic stem cell transplantation", "Rituximab therapy to deplete B cells", "Interleukin-2 supplementation"], "answer": "A", "answer_index": 0, "explanation": "Intravenous immunoglobulin replacement is the cornerstone of therapy for common variable immunodeficiency to prevent infections by providing passive immunity. Prophylactic antibiotics are adjunctive but not sufficient alone, while transplantation is reserved for severe cases with cellular defects. Rituximab and IL-2 are not standard for this humoral immunodeficiency.", "generator_model": "grok-4-0709", "seed": 131, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Immunology", "abms_specialty": "Immunology", "abms_source": "target_topic", "source_label_raw": "Immunology", "source_quiz_id": "20251216T182308874Z_grok-4-0709_seed131", "source_question_id": "20251216T182308874Z_grok-4-0709_seed131-003", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251216T182308874Z_grok-4-0709_seed131", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T182308874Z_grok-4-0709_seed131.jsonl", "pred": "A", "model_outputs": "The answer is (A)"}, {"quiz_id": "ABMS20260101_grok-4-0709_p03", "question_id": "ABMS20260101_grok-4-0709_p03-007", "question": "A 65-year-old man with giant cell arteritis on prednisone taper develops jaw claudication and vision loss. ESR is 80 mm/hr, and temporal artery biopsy is negative. CTA shows aortic arch involvement. What is the most appropriate escalation in therapy?", "options": ["Increase prednisone to 60 mg daily", "Add methotrexate", "Initiate tocilizumab", "Start cyclophosphamide", "Perform temporal artery ultrasound"], "answer": "C", "answer_index": 2, "explanation": "Tocilizumab, an IL-6 inhibitor, is indicated for refractory giant cell arteritis with large vessel involvement, reducing relapse and steroid requirements. High-dose prednisone is initial but inadequate for escalation in biopsy-negative cases. Methotrexate is steroid-sparing but less effective for vision-threatening disease.", "generator_model": "grok-4-0709", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Rheumatology/Musculoskeletal", "abms_specialty": "Rheumatology/Musculoskeletal", "abms_source": "topics_mapped", "source_label_raw": "rheumatology", "source_quiz_id": "20251201T041413890Z_grok-4-0709_seed124", "source_question_id": "20251201T041413890Z_grok-4-0709_seed124-010", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251201T041413890Z_grok-4-0709_seed124", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251201T041413890Z_grok-4-0709_seed124.jsonl", "pred": "C", "model_outputs": "The answer is (C)"}, {"quiz_id": "ABMS20260101_grok-4-0709_p03", "question_id": "ABMS20260101_grok-4-0709_p03-008", "question": "A 25-year-old man with HIV on antiretroviral therapy presents with headache and seizures. CSF analysis shows lymphocytic pleocytosis, elevated protein, and positive India ink stain. MRI reveals multiple ring-enhancing lesions. CD4 count is 150 cells/μL. What is the most appropriate initial management?", "options": ["Start amphotericin B and flucytosine induction", "Initiate pyrimethamine and sulfadiazine", "Administer acyclovir for herpes encephalitis", "Use intravenous ceftriaxone for bacterial meningitis", "Prescribe albendazole for neurocysticercosis"], "answer": "A", "answer_index": 0, "explanation": "Cryptococcal meningitis in HIV presents with India ink-positive CSF and ring-enhancing lesions, requiring induction with amphotericin B and flucytosine for clearance. Toxoplasmosis lacks India ink positivity, while herpes, bacterial, and parasitic etiologies do not match the CSF findings. Prompt antifungal therapy reduces mortality in this setting.", "generator_model": "grok-4-0709", "seed": 131, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Infectious Disease", "abms_specialty": "Infectious Disease", "abms_source": "target_topic", "source_label_raw": "Infectious Disease", "source_quiz_id": "20251216T182308874Z_grok-4-0709_seed131", "source_question_id": "20251216T182308874Z_grok-4-0709_seed131-011", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251216T182308874Z_grok-4-0709_seed131", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T182308874Z_grok-4-0709_seed131.jsonl", "pred": "A", "model_outputs": "The answer is (A)"}, {"quiz_id": "ABMS20260101_grok-4-0709_p03", "question_id": "ABMS20260101_grok-4-0709_p03-009", "question": "A 55-year-old man with metastatic non-small cell lung cancer harboring an EGFR exon 20 insertion mutation progresses on osimertinib. Tumor biopsy shows transformation to small cell histology. He has good performance status. What is the most appropriate systemic therapy?", "options": ["Continue osimertinib with added chemotherapy", "Switch to amivantamab", "Initiate etoposide and platinum-based chemotherapy", "Use mobocertinib as targeted therapy", "Administer immune checkpoint inhibitor monotherapy"], "answer": "C", "answer_index": 2, "explanation": "Transformation to small cell lung cancer in EGFR-mutant NSCLC requires treatment as small cell carcinoma with etoposide-platinum chemotherapy, which has shown responses in such cases. Continuing EGFR inhibitors is ineffective post-transformation, while amivantamab and mobocertinib target specific exon 20 insertions but not small cell histology. Immunotherapy has limited efficacy in transformed disease.", "generator_model": "grok-4-0709", "seed": 131, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Medical Oncology", "abms_specialty": "Medical Oncology", "abms_source": "target_topic", "source_label_raw": "Medical Oncology", "source_quiz_id": "20251216T182308874Z_grok-4-0709_seed131", "source_question_id": "20251216T182308874Z_grok-4-0709_seed131-005", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251216T182308874Z_grok-4-0709_seed131", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T182308874Z_grok-4-0709_seed131.jsonl", "pred": "C", "model_outputs": "The answer is (C) "}, {"quiz_id": "ABMS20260101_grok-4-0709_p03", "question_id": "ABMS20260101_grok-4-0709_p03-010", "question": "A 12-year-old boy with hereditary angioedema type I presents with recurrent abdominal pain and facial swelling. Laboratory studies show C1 inhibitor level 20% of normal and low C4. He has breakthrough episodes despite prophylactic danazol. What is the most appropriate escalation in therapy?", "options": ["Switch to tranexamic acid prophylaxis", "Initiate subcutaneous C1 inhibitor replacement", "Add icatibant for on-demand treatment", "Use ecallantide for acute attacks", "Administer fresh frozen plasma infusions"], "answer": "B", "answer_index": 1, "explanation": "Subcutaneous C1 inhibitor replacement is effective for prophylaxis in hereditary angioedema with breakthrough on androgens, providing targeted replacement of the deficient protein. Tranexamic acid is less effective for type I, while icatibant and ecallantide are for acute treatment, not prophylaxis. Fresh frozen plasma carries risks and is not preferred for long-term use.", "generator_model": "grok-4-0709", "seed": 131, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Allergy/Immunology", "abms_specialty": "Allergy/Immunology", "abms_source": "target_topic", "source_label_raw": "Allergy/Immunology", "source_quiz_id": "20251216T182308874Z_grok-4-0709_seed131", "source_question_id": "20251216T182308874Z_grok-4-0709_seed131-006", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251216T182308874Z_grok-4-0709_seed131", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T182308874Z_grok-4-0709_seed131.jsonl", "pred": "B", "model_outputs": "In hereditary angioedema type I, breakthrough attacks while on danazol indicate a need for a more potent prophylactic regimen. Subcutaneous C1 inhibitor replacement (e.g., Haegarda) provides routine, long‑term prevention of angioedema attacks and is superior in efficacy and safety to androgen therapy in children and adolescents.  \n\nSwitching to tranexamic acid would likely be less effective, and adding on‑demand agents (icatibant, ecallantide) or using fresh frozen plasma do not address the underlying prophylactic failure.  \n\nThe answer is (B)"}]